Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
Samuli Kangaslampi, Aino Hausen, Tarina Rauteenmaa
Journal of Psychoactive Drugs 2020 DOI: 10.1080/02791072.2020.1767321 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 288 |
| Population | People retrospectively reporting on their first time using a psychedelic |
| Topics | LSD Mystical experience Psilocybin |
| Keywords | Psychedelics Well-being |
| Key findings | The Finnish MEQ30 shows internal consistency reliability and preliminary evidence for criterion and discriminant validity, with a four-factor structure fitting best; mystical experiences were associated with positive changes in relationships with nature and oneself and in creativity, and were more common with larger doses. |
Abstract
Despite their acutely inebriating and sometimes unpleasant effects, some people report positive changes in life satisfaction, well-being, or mental health after taking psychedelic drugs. One explanation may be the ability of psychedelics to trigger mystical-type experiences. We examined the validity, reliability, and factor structure of a novel Finnish translation of the Revised Mystical Experiences Questionnaire (MEQ30) among 288 people retrospectively reporting on their first time using a psychedelic. We found evidence for internal consistency reliability and preliminary evidence for criterion and discriminant validity of the Finnish MEQ30. A four-factor structure with factors for mystical qualities, positive mood, transcendence, and ineffability had the best, fair to reasonable fit to the data. MEQ30 scores and having a full mystical experience were highly associated with describing the experience as mystical, spiritual, or religious, and as personally significant, and somewhat associated with the experience being sad or difficult. Mystical experiences were especially associated with positive changes in relationships with nature and oneself and in creativity. Mystical experiences were more common with larger doses. Increasing research suggests mystical-type experiences to relate to positive changes after taking psychedelics. The Finnish MEQ30 is able to tap into relevant information about this aspect of people's psychedelic experiences.
Comparable studies
Other cross-sectional and survey studies on mystical experience, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Of Roots and Fruits: A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences Self-selected participants who reported a religious, spiritual, or mystical experience | 2016 | Cross-sectional survey | n = 739 |
| Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... | 2012 | Cross-sectional survey | n = 337 |
| Peak Experiences: Some Empirical Tests Random sample of adults in the San Francisco Bay Area | 1978 | Cross-sectional survey | |
| Peak Experience Tendencies | 1982 | Cross-sectional survey | |
| Rhythmic Chanting and Mystical States across Traditions. Regular chanters across 33 countries | 2021 | Cross-sectional survey | n = 464 |
Citations in the library
Cited by 26
- Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacology & Translational Science March 5, 2021
- The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychology Open July 1, 2020
- Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics Journal of Psychopharmacology November 16, 2023
- Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia Psychoactives May 25, 2023
- Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials. Journal of Psychoactive Drugs 2023
and 21 more in the library
Cites 36
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 31 more in the library